[1]
Lebwohl, M., Stein Gold, L., Gooderham, M.J., Papp, K.A., Ferris, L.K., Adam, D.N., Hong, H.C.- ho, Kircik, L.H., Zirwas, M., Burnett, P. and Higham, R. 2023. Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. SKIN The Journal of Cutaneous Medicine. 7, 4 (Jul. 2023), s218. DOI:https://doi.org/10.25251/skin.7.supp.218.